🇺🇸 FDA
Pipeline program

Berotralstat, Berotralstat, Berotralstat, BEROTRALSTAT, Berotralstat

BCX7353-312

Approved small_molecule active

Quick answer

Berotralstat, Berotralstat, Berotralstat, BEROTRALSTAT, Berotralstat for Hereditary Angioedema is a Approved program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Hereditary Angioedema
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials